At the news
? NEUTRALIMPACT 3/10 CLUSTER filed Sep 14, 2026 at 16:59 ET
Two insiders at Ligand Pharmaceuticals sold a combined $427K in open-market transactions over a one-week window. The sales are small relative to the $5.7B market cap (0.007%), and the cluster consists of a CLO and a director, not the CEO or CFO, limiting the informational signal.
- Two insiders sold shares between Sept 3 and Sept 10, 2026
- Total sale value: $427K (0.007% of $5.7B market cap)
- Sellers: CLO Andrew Reardon ($85K) and Director Martine Zimmermann ($342K)
- No CEO or CFO sales in the cluster
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access